Rigel Pharmaceuticals, Incorporated

Jim Bernstein

John McLaughlin

Zachary Pincus

John Mclaughlin

Certain aspects of this disclosure relate to a screening method. In general terms, the screening assay comprises contacting test cells with a test compound to provide contacted test cells, obtaining values for a plurality of cytological attributes of the contacted test cells, and scoring the cells using the values to provide a likelihood score for at least one of a plurality of classifiers, where the plurality of classifiers are defined using values for cytological attributes obtained from cells that have been contacted with compounds of known mode of action.

Growing community of inventors

Brisbane, CA, United States of America

Jim Bernstein